Apogee Therapeutics CEO sells shares worth $732,692 By Investing.com

Apogee Therapeutics CEO sells shares worth 732692 By Investingcom

Michael Thomas Henderson, the Chief Executive Officer of Apogee (NASDAQ:) Therapeutics, Inc….

www.investing.com

More posts

US bans use of Red No.3 dye in food, drugs over potential cancer links By Reuters

January 16, 2025
Exclusive-Trump team asks three US senior career diplomats to resign, sources say By Reuters

January 16, 2025
US regulators propose capping nicotine in cigarettes at non-addictive levels By Reuters

January 16, 2025
Analysts eye Bitcoin rally after bullish CPI print

January 16, 2025